234 related articles for article (PubMed ID: 31821039)
21. A metabolomic analysis of omega-3 fatty acid-mediated attenuation of western diet-induced nonalcoholic steatohepatitis in LDLR-/- mice.
Depner CM; Traber MG; Bobe G; Kensicki E; Bohren KM; Milne G; Jump DB
PLoS One; 2013; 8(12):e83756. PubMed ID: 24358308
[TBL] [Abstract][Full Text] [Related]
22. Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis Model.
Nakanishi K; Kaji K; Kitade M; Kubo T; Furukawa M; Saikawa S; Shimozato N; Sato S; Seki K; Kawaratani H; Moriya K; Namisaki T; Yoshiji H
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31163617
[TBL] [Abstract][Full Text] [Related]
23. Fenretinide inhibits obesity and fatty liver disease but induces Smpd3 to increase serum ceramides and worsen atherosclerosis in LDLR
Thompson D; Mahmood S; Morrice N; Kamli-Salino S; Dekeryte R; Hoffmann PA; Doherty MK; Whitfield PD; Delibegović M; Mody N
Sci Rep; 2023 Mar; 13(1):3937. PubMed ID: 36894641
[TBL] [Abstract][Full Text] [Related]
24. Modulating sphingosine 1-phosphate receptor signaling skews intrahepatic leukocytes and attenuates murine nonalcoholic steatohepatitis.
Liao CY; Barrow F; Venkatesan N; Nakao Y; Mauer AS; Fredrickson G; Song MJ; Sehrawat TS; Dasgupta D; Graham RP; Revelo XS; Malhi H
Front Immunol; 2023; 14():1130184. PubMed ID: 37153573
[TBL] [Abstract][Full Text] [Related]
25. Acid Sphingomyelinase Deficiency Prevents Diet-induced Hepatic Triacylglycerol Accumulation and Hyperglycemia in Mice.
Deevska GM; Rozenova KA; Giltiay NV; Chambers MA; White J; Boyanovsky BB; Wei J; Daugherty A; Smart EJ; Reid MB; Merrill AH; Nikolova-Karakashian M
J Biol Chem; 2009 Mar; 284(13):8359-68. PubMed ID: 19074137
[TBL] [Abstract][Full Text] [Related]
26. Modulation of SIRT1-mediated signaling cascades in the liver contributes to the amelioration of nonalcoholic steatohepatitis in high fat fed middle-aged LDL receptor knockout mice by dihydromyricetin.
Zeng Y; Hua YQ; Wang W; Zhang H; Xu XL
Biochem Pharmacol; 2020 May; 175():113927. PubMed ID: 32217100
[TBL] [Abstract][Full Text] [Related]
27. 2, 3, 4', 5-tetrahydroxystilbene-2-0-β-d Glycoside Attenuates Age- and Diet-Associated Non-Alcoholic Steatohepatitis and Atherosclerosis in LDL Receptor Knockout Mice and Its Possible Mechanisms.
Xu J; Peng Y; Zeng Y; Hua YQ; Xu XL
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30939745
[TBL] [Abstract][Full Text] [Related]
28. Acid sphingomyelinase plays a key role in palmitic acid-amplified inflammatory signaling triggered by lipopolysaccharide at low concentrations in macrophages.
Jin J; Zhang X; Lu Z; Perry DM; Li Y; Russo SB; Cowart LA; Hannun YA; Huang Y
Am J Physiol Endocrinol Metab; 2013 Oct; 305(7):E853-67. PubMed ID: 23921144
[TBL] [Abstract][Full Text] [Related]
29. Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in
Samsoondar JP; Burke AC; Sutherland BG; Telford DE; Sawyez CG; Edwards JY; Pinkosky SL; Newton RS; Huff MW
Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):647-656. PubMed ID: 28153881
[TBL] [Abstract][Full Text] [Related]
30. [Establishment and evaluation of a mouse model of nonalcoholic steatohepatitis-related hepatocellular carcinoma].
Luo Y; Yang WJ; Chen JY; Zhang J; Zeng XD; Zhuang ZJ; Zang SF; Zhou G; Di CH; Shi JP
Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):279-84. PubMed ID: 27470627
[TBL] [Abstract][Full Text] [Related]
31. RAGE deficiency does not affect non-alcoholic steatohepatitis and atherosclerosis in Western type diet-fed Ldlr
Bijnen M; Beelen N; Wetzels S; Gaar JV; Vroomen M; Wijnands E; Scheijen JL; van de Waarenburg MPH; Gijbels MJ; Cleutjens JP; Biessen EAL; Stehouwer CDA; Schalkwijk CG; Wouters K
Sci Rep; 2018 Oct; 8(1):15256. PubMed ID: 30323247
[TBL] [Abstract][Full Text] [Related]
32. Liraglutide improves hepatic steatosis and metabolic dysfunctions in a 3-week dietary mouse model of nonalcoholic steatohepatitis.
Duparc T; Briand F; Trenteseaux C; Merian J; Combes G; Najib S; Sulpice T; Martinez LO
Am J Physiol Gastrointest Liver Physiol; 2019 Oct; 317(4):G508-G517. PubMed ID: 31460789
[TBL] [Abstract][Full Text] [Related]
33. Identification and evaluation of neutral sphingomyelinase 2 inhibitors.
Lee DH; Kim SH; Ahn KH; Kim SK; Choi JM; Ji JE; Won JH; Park YH; Lim C; Kim S; Kim DK
Arch Pharm Res; 2011 Feb; 34(2):229-36. PubMed ID: 21380806
[TBL] [Abstract][Full Text] [Related]
34. Cangju Qinggan Jiangzhi Decoction Reduces the Development of NonAlcoholic Steatohepatitis and Activation of Kupffer Cells.
Cheng Y; Chen T; Ping J; Chen J
Cell Physiol Biochem; 2018; 48(3):971-982. PubMed ID: 30036865
[TBL] [Abstract][Full Text] [Related]
35. Saturated fatty acid combined with lipopolysaccharide stimulates a strong inflammatory response in hepatocytes in vivo and in vitro.
Li Y; Lu Z; Ru JH; Lopes-Virella MF; Lyons TJ; Huang Y
Am J Physiol Endocrinol Metab; 2018 Nov; 315(5):E745-E757. PubMed ID: 29989851
[TBL] [Abstract][Full Text] [Related]
36. FTY720/fingolimod decreases hepatic steatosis and expression of fatty acid synthase in diet-induced nonalcoholic fatty liver disease in mice.
Rohrbach TD; Asgharpour A; Maczis MA; Montefusco D; Cowart LA; Bedossa P; Sanyal AJ; Spiegel S
J Lipid Res; 2019 Jul; 60(7):1311-1322. PubMed ID: 31110049
[TBL] [Abstract][Full Text] [Related]
37. FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation.
Yao J; Zhou CS; Ma X; Fu BQ; Tao LS; Chen M; Xu YP
World J Gastroenterol; 2014 Oct; 20(39):14430-41. PubMed ID: 25339829
[TBL] [Abstract][Full Text] [Related]
38. Cellular cholesterol accumulation modulates high fat high sucrose (HFHS) diet-induced ER stress and hepatic inflammasome activation in the development of non-alcoholic steatohepatitis.
Bashiri A; Nesan D; Tavallaee G; Sue-Chue-Lam I; Chien K; Maguire GF; Naples M; Zhang J; Magomedova L; Adeli K; Cummins CL; Ng DS
Biochim Biophys Acta; 2016 Jul; 1861(7):594-605. PubMed ID: 27090939
[TBL] [Abstract][Full Text] [Related]
39. Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease.
Lee HJ; Yeon JE; Ko EJ; Yoon EL; Suh SJ; Kang K; Kim HR; Kang SH; Yoo YJ; Je J; Lee BJ; Kim JH; Seo YS; Yim HJ; Byun KS
World J Gastroenterol; 2015 Dec; 21(45):12787-99. PubMed ID: 26668503
[TBL] [Abstract][Full Text] [Related]
40. β-Cryptoxanthin alleviates diet-induced nonalcoholic steatohepatitis by suppressing inflammatory gene expression in mice.
Kobori M; Ni Y; Takahashi Y; Watanabe N; Sugiura M; Ogawa K; Nagashimada M; Kaneko S; Naito S; Ota T
PLoS One; 2014; 9(5):e98294. PubMed ID: 24858832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
